Skip to main content
. 2019 Jul 4;8(10):4699–4708. doi: 10.1002/cam4.2381

Figure 5.

Figure 5

Relationship between TMB‐H and MSI, dMMR, and PD‐L1 AMP across cancer types in Chinese patients. A, Overlapping distributions of TMB, MSI, dMMR and PD‐L1 AMP. B, Proportions of TMB‐H patients positive for other biomarkers. C, TMB in all samples with (n = 28) or without (n = 922) PD‐L1 AMP. dMMR, DNA mismatch repair deficiency; MSI, microsatellite instability; PD‐L1 AMP, PD‐L1 amplification; TMB, tumor mutation burden; TMB‐H, high TMB